Publicaciones en las que colabora con Juan Pablo de Torres Tajes (39)

2024

  1. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 10-15

  2. Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 2, pp. 95-100

  3. Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma

    eBioMedicine, Vol. 102

2023

  1. Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients

    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, Vol. 29, Núm. 10, pp. 1100-1108

2022

  1. Chest CT-assessed comorbidities and all-cause mortality risk in COPD patients in the BODE cohort

    Respirology, Vol. 27, Núm. 4, pp. 286-293

2021

  1. Endobronchial autologous bone marrow-mesenchymal stromal cells in idiopathic pulmonary fibrosis: a phase I trial

    ERJ Open Research, Vol. 7, Núm. 2, pp. 00773-2020

  2. Exploring the Impact of Lung Cancer Screening on Lung Cancer Mortality of Smokers With Obstructive Lung Disease: Analysis of the NLST-ACRIN Cohort

    Archivos de Bronconeumologia, Vol. 57, Núm. 1, pp. 36-41

  3. Nocturnal hypoxemia and CT determined pulmonary artery enlargement in smokers

    Journal of Clinical Medicine, Vol. 10, Núm. 3, pp. 1-12

  4. Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients

    Archivos de Bronconeumologia, Vol. 57, Núm. 8, pp. 533-539

  5. Surgical Outcomes in a Lung Cancer-Screening Program Using Low Dose Computed Tomography

    Archivos de Bronconeumologia, Vol. 57, Núm. 2, pp. 101-106

2020

  1. Exploring the association between emphysema phenotypes and low bone mineral density in smokers with and without copd

    International Journal of COPD, Vol. 15, pp. 1823-1829

  2. Immune-related adverse events as predictors of response in cancer patients undergoing immunotherapy

    Radiologia, Vol. 62, Núm. 2, pp. 131-138

  3. Prevalence and burden of bronchiectasis in a lung cancer screening program

    PLoS ONE, Vol. 15, Núm. 4

  4. Somatotypes trajectories during adulthood and their association with copd phenotypes

    ERJ Open Research, Vol. 6, Núm. 3, pp. 1-9

2019

  1. B cell-adaptive immune profile in emphysema-predominant chronic obstructive pulmonary disease

    American Journal of Respiratory and Critical Care Medicine

  2. Emphysema phenotypes and lung cancer risk

    PLoS ONE, Vol. 14, Núm. 7

  3. The prevalence of obstructive lung disease in a lung cancer screening cohort: Analysis of the national lung screening trial–American College of radiology image network cohort

    Annals of the American Thoracic Society

  4. Trabecular bone score in active or former smokers with and without COPD

    PLoS ONE, Vol. 14, Núm. 2

2018

  1. Pulmonary arterial enlargement predicts long-term survival in COPD patients

    PLoS ONE, Vol. 13, Núm. 4

2017

  1. Clinical Features of Smokers With Radiological Emphysema But Without Airway Limitation

    Chest, Vol. 151, Núm. 2, pp. 358-365